glp-1 therapies success rate Proportion of Patients Who Discontinued RA Therapy, n=4791 GLP-1 Drugs Market Size to
Description
Trusted Telehealth Infrastructure What happens next
Toothpaste and fluoride products may reduce symptoms temporarily, but they do not address the exposed root surface that causes sensitivity
GLP-1 agonists do not directly impair kidney function, but weight loss and dehydration risk can affect clearance
A.MiyazakiN
Patients with active or poorly controlled Crohn's disease face higher risks of adverse gastrointestinal effects from GLP-1 therapy
